Studies from our group, and others, have identified that the pathway directed along the Insulin-like Growth Factor (IGF) axis (specifically involving IGF-I, IGFBP3, down the PI3K/Akt cascade to FOXO1) is strongly associated with breast cancer outcomes. Here, FOXO1 is linked to breast cancer.